Timedora

2 Hypertension

Learn how hypertension is classified, measured, assessed, and treated, and how to recognize complications that need urgent or emergency attention.

Understanding and classifying

is persistently elevated arterial blood pressure and often causes no symptoms. Because it may be silent while increasing the risk of damage to the heart, brain, kidneys, eyes, and blood vessels, accurate measurement and follow-up are essential. A diagnosis should rely on properly obtained readings and clinical evaluation, not on a single routine measurement.

For nonpregnant adults, the 2025 AHA/ACC guideline classifies blood pressure using systolic and diastolic readings. A reading in either the systolic or diastolic range may determine the category.

  • Normal: systolic below 120120 mm Hg and diastolic below 8080 mm Hg.

  • Elevated: systolic from 120120 to 129129 mm Hg and diastolic below 8080 mm Hg.

  • Stage 1 : systolic from 130130 to 139139 mm Hg or diastolic from 8080 to 8989 mm Hg.

  • Stage 2 : systolic at least 140140 mm Hg or diastolic at least 9090 mm Hg.

The general treatment goal is below 130/80130/80 mm Hg, with individual considerations for some patients. Confirming elevated readings outside the clinic may help identify or .

Obtaining accurate readings

Prepare for a reliable reading by having the patient avoid smoking, exercise, and caffeine for 3030 minutes beforehand and empty their bladder. The patient should sit quietly for at least 55 minutes, with the back supported, feet flat, and legs uncrossed. Place a correctly sized cuff on a bare upper arm, rest the arm at heart level, and have the patient remain quiet during measurement.

For home monitoring, teach patients to take at least two readings 11–22 minutes apart, record the readings, and share the log with the care team. A reading such as 136/84136/84 mm Hg falls in stage 1 because either the systolic value of 130130–139139 mm Hg or the diastolic value of 8080–8989 mm Hg meets that category.

Nursing assessment and monitoring

Nursing assessment includes reviewing blood pressure trends, medication use, and barriers to adherence. Screen for symptoms or signs of , and monitor relevant laboratory results, such as kidney function and electrolytes, when indicated by the patient's condition or medications.

After treatment changes, assess dizziness or orthostatic symptoms. If a patient reports dizziness after a medication change, assess symptoms and blood pressure, including positional readings when appropriate, and report the findings. Reinforce follow-up rather than advising unsupervised medication changes.

Complications and urgent response

Long-term uncontrolled can injure the heart, brain, kidneys, retina, and arteries. Possible outcomes include myocardial infarction, heart failure, stroke, chronic kidney disease, vision loss, and peripheral arterial disease. New chest pain, shortness of breath, weakness, numbness, confusion, difficulty speaking, or acute vision changes require urgent assessment.

A repeated blood pressure above 180/120180/120 mm Hg needs prompt attention. If this severe reading is accompanied by concerning symptoms such as chest pain, shortness of breath, weakness, vision change, or difficulty speaking, call emergency services. For example, a repeat reading of 184/122184/122 mm Hg with sudden weakness and difficulty speaking calls for emergency services.

If the repeat reading remains above 180/120180/120 mm Hg without symptoms, contact a health professional promptly for assessment and treatment guidance. Do not independently take extra doses or attempt rapid lowering.

Treatment decisions

Treatment combines lifestyle measures and, when indicated, medication. The 2025 guideline recommends medication for adults with an average blood pressure of at least 140/90140/90 mm Hg, and for selected adults at or above 130/80130/80 mm Hg based on cardiovascular disease, prior stroke, diabetes, chronic kidney disease, or estimated cardiovascular risk.

For lower-risk adults with stage 1 , medication is recommended if blood pressure remains at or above 130/80130/80 mm Hg after an initial lifestyle trial of 33–66 months. For stage 2 , starting two first-line medicines from different classes is preferred; these are often provided in one combination pill. The treatment plan and goal should be individualized.

Lifestyle and medication education

Lifestyle teaching includes following a heart-healthy eating pattern such as , reducing sodium, pursuing a healthy weight, engaging in regular physical activity, avoiding tobacco, managing stress, and limiting or avoiding alcohol.

Patients should take medicines as prescribed and continue them even when they feel well. They should consult their clinician before stopping a medicine or changing a dose. Because is commonly symptom-free, feeling normal is not a reason to stop treatment without clinical advice.

Medication groups and safe use

Common medication groups include thiazide-type diuretics, , angiotensin-receptor blockers (), and calcium-channel blockers. The choice depends on the patient's health conditions, response, adverse effects, and laboratory findings. Nurses reinforce the medication plan, assess adherence and side effects, and encourage follow-up and home monitoring.

Patients should ask a clinician or pharmacist before using over-the-counter medicines or supplements. Some products, including certain decongestants and NSAIDs, can raise blood pressure or interact with treatment.